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is a greater need for more precise definition of
putative human tumour antigens. Exploita-
tion of such antigens in immunotherapy, on
the presumption that they exist, has yielded
only limited evidence of improved prognosis.
This is evident from the reviewr chapter by
Mastrangelo et al. on immunotherapeutic
studies on cancer patients. There is little
apparent cognizance of the dilemma which
faces the increasing number of clinicians
given to immunotherapeutic procedures, viz.
that a diversity of animal studies reveal that
immunotherapy has limited success, even
against the most antigenic of experimental
tumours. Indeed, it is somewhat ironic that
disappointing results in animals have not
prevented the widespread use of immuno-
therapy in man.
Other chapters are variously devoted to
macrophages and neoplasia (AMansell and
Diluzio) and anergy, anti-antibodies and
immune-complex disease (Terry et al.). Much
of the material presented has appeared else-
where, so that few will find this volume
essential.
M. MOORE
Review of Gastric and Colo-rectal
Cancers. (ConferenceReport) (1977) London:
MRC. 27 pp.
This Meeting reviewed the w%hole area of
malignant, disease ofthegastro-intestinal tract
in terms of instance, epidemiology, carcino-
genesis, diagnosis (including education) and
therapy. The details of the United States
Workshop (1977) on large-bowel cancer were
also reported.
From these items, various points are of
interest. The first is that 1 in 20 in the United
Kingdom die of carcinoma of the gastro-
intestinal tract. It was felt that more atten-
tion should be paid to the epidemiology ofthis
group of diseases, and in practical terms, the
Office of Population and Censuses should not
be deprived of resources. Dietary and other
carcinogenic factors certainly require more
interest and financial support. In the diag-
nostic section, the need for support for
programmes involved in early diagnosis was
emphasized.
In the sections on therapy, identification of
wrhy patients did better at specialist centres
needed explanation as soon as possible. The
use ofneutron therapy, particularly in gastric
carcinoma should be extended to early cases.
Adjuvant chemotherapy as the basis of con-
trolled clinical trials should bere-evaluated. It
wNias suggested that there should be 3 co-
ordinating groups for gastro-intestinal malig-
nant diseases: in gastric cancer, colo-rectal
cancer and lymphoma of the gastro-intestinal
tract.
Meetings suchasthisserve to highlight areas
of progress and lack of progress and are
invaluable at the national level for the
organization of clinical trials in these malig-
nant diseases.
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